Intra-arterial continuous infusion for treatment of pancreatic and biliary tract cancer: A dose-escalation study of fluorouracil combined with gemcitabine

International Journal of Pancreatology

Volumn 27, Issue 3, 2000, Pages 225-233

  Zanon, C ^a   Alabiso, O ^a   Grosso, M ^a   Buosi, R ^a   Chiappino, I ^a   Clara, R ^a   Satolli, A ^a   Zai, S ^a   Bortolini, M ^a   Botta, M ^a   Mussa, A ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

5 FU; Arterial infusion; Gemcitabine; Neoplasm; Pancreas; Phase I

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; GEMCITABINE;

ADULT; AGED; ARTICLE; BILIARY TRACT CANCER; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG INFUSION; DRUG SAFETY; DRUG TOLERABILITY; DRUG TUMOR LEVEL; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; LIVER METASTASIS; MALE; PANCREAS CANCER; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS;

EID: 0033882637     PISSN: 01694197     EISSN: None     Source Type: Journal    
DOI: 10.1385/ijgc:27:3:225     Document Type: Article

References (30)

1. Pancreatic cancer: The greatest oncological challenge
2. Pancreatic cancer: Overview of current and future therapeutic approaches
3. Carcinoma of the extrahepatic bile ducts: Histologic types, stage of disease, grade and survival rates
4. Chemotherapy of pancreatic and gastric carcinoma: A controlled evaluation of combination of 5-FU with nitrosoureas and 'lactones'
5. Continuous 5-FU infusion in carcinoma of the pancreas
6. Treatment of advanced pancreatic carcinoma with a combination of protracted infusional 5-FU plus weekly cisplatin for pancreatic carcinoma. A Mid Atlantic Oncology Program Study
7. Clinical response benefit in patients with advanced pancreatic cancer. Role of gemcitabine
8. Phase II trial of gemcitabine (2,2'-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas
9. A phase II trial of gemcitabine in patients with 5-FU refractory pancreas cancer
10. Improvements in survival and clinical benefits with gemcitabine as first-line therapy for patients with advanced pancreatic cancer
11. Regional chemotherapy for inoperable pancreatic carcinoma
12. Transaxillary access to perform hepatic artery infusion (HAI) for secondary or primitive hepatic tumors
13. Transaxillary access to perform hepatic artery infusion (HAI) for secondary or primitive hepatic tumours [letter]
14. The percutaneous placement of intra-arterial catheters with reservoirs for subcutaneous infusion.The technique and preliminary results
15. Laparoscopic measurement of pancreatic blood flow
16. Intra-arterial chemotherapy with MMC, CDDP and 5-FU for non resectable pancreatic cancer. A phase II study
17. Treatment of advanced pancreatic cancer with regional chemotherapy plus hemofiltration
18. Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma. Phase I and II pilot study
19. Regional chemotherapy in advanced pancreatic carcinoma
20. Celiac artery adjuvant chemotherapy. Results of a prospective trial
21. Intra-arterial chemotherapy for locally advanced and metastatic pancreatic cancer
22. Palliative and adjuvant regional chemotherapy in pancreatic cancer
23. Intra-arterial adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic cancer: Significant reduction in occurrence of liver metastases
24. Liver perfusion via both the hepatic artery and portal vein to prevent hepatic metastasis after extended pancreatectomy for adenocarcinoma of the pancreas
25. Adjuvant therapy of Dukes' A, B and C adenocarcinoma of the colon with portal veinfluorouracil hepatic infusion: Preliminary results of National Surgical Breast and Bowel Adjuvant Protocol C-02
26. Multimodal therapies in ductal pancreatic cancer
27. Ex vivo ATP tumor testing of gemcitabine for combination chemotherapy and biochemical modulation
28. Action of 2',2'-difluorodeoxycytidine on DNA synthesis
29. Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer
30. Percutaneous implantation of arterial port-a-cath via trans-subclavian access